Cargando…

Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center

BACKGROUND: Margin positivity after gastric cancer resection is associated with poorer outcomes. However, the prognostic factors and the choice of postoperative adjuvant treatment of patients with positive margin (PM) after gastrectomy are still being debated. METHODS: A single-center, retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaojie, Zhao, Lulu, Niu, Penghui, Wang, Tongbo, Wang, Wanqing, Sun, Chongyuan, Li, Zefeng, Chen, Yingtai, Zhao, Dongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847385/
https://www.ncbi.nlm.nih.gov/pubmed/35186712
http://dx.doi.org/10.3389/fonc.2021.794032
_version_ 1784652037644877824
author Zhang, Xiaojie
Zhao, Lulu
Niu, Penghui
Wang, Tongbo
Wang, Wanqing
Sun, Chongyuan
Li, Zefeng
Chen, Yingtai
Zhao, Dongbing
author_facet Zhang, Xiaojie
Zhao, Lulu
Niu, Penghui
Wang, Tongbo
Wang, Wanqing
Sun, Chongyuan
Li, Zefeng
Chen, Yingtai
Zhao, Dongbing
author_sort Zhang, Xiaojie
collection PubMed
description BACKGROUND: Margin positivity after gastric cancer resection is associated with poorer outcomes. However, the prognostic factors and the choice of postoperative adjuvant treatment of patients with positive margin (PM) after gastrectomy are still being debated. METHODS: A single-center, retrospective analysis was conducted for patients with PM after gastrectomy from the China National Cancer Center Gastric Cancer Database (NCCGCDB) from 1998 to 2018. Univariate and multivariate Cox regression analyses were performed to identify prognostic factors of overall survival (OS) and recurrence-free survival (RFS). RESULTS: A total of 449 patients were included in the study, including 192 (42.8%) in the proximal PM group (PPM), 205 (45.7%) in the distal PM group (DPM), and 52 (11.6%) in the bilateral PM group (BPM). The 3- and 5-year OS rates for the PM patients investigated were 47.5% and 39.3%, respectively, and the 3- and 5-year RFS rates were 60.0% and 53.6%, respectively. Multivariate Cox regression analysis proved total gastrectomy (hazard ratio (HR): 1.783, 95%CI: 1.133–2.805, p = 0.012), pT4 (HR: 5.264, 95%CI: 1.493–18.565, p = 0.01), pN2 (HR: 2.263, 95%CI: 1.164–4.397, p = 0.016), pN3 (HR: 2.327, 95%CI: 1.233–4.393, p = 0.009), and combined resection (HR: 1.952, 95%CI: 1.256–3.034, p = 0.003) to be independent risk factors of OS, and pT3 (HR: 9.257, 95%CI: 1.152–74.386, p = 0.036) and pT4 (HR: 11.361, 95%CI: 1.469–87.847, p = 0.020) to be independent risk factors for RFS. Adjuvant chemotherapy prolonged OS in the PPM group (p = 0.032) and prolonged RFS in the PPM group (p < 0.001) and the DPM group (p = 0.035) compared with surgery alone. CONCLUSIONS: Advanced pathologic stage was associated with poor prognosis, and postoperative adjuvant chemotherapy might be recommended in PM patients after gastrectomy. Still, further prospective trials are warranted to verify and support our conclusions.
format Online
Article
Text
id pubmed-8847385
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88473852022-02-17 Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center Zhang, Xiaojie Zhao, Lulu Niu, Penghui Wang, Tongbo Wang, Wanqing Sun, Chongyuan Li, Zefeng Chen, Yingtai Zhao, Dongbing Front Oncol Oncology BACKGROUND: Margin positivity after gastric cancer resection is associated with poorer outcomes. However, the prognostic factors and the choice of postoperative adjuvant treatment of patients with positive margin (PM) after gastrectomy are still being debated. METHODS: A single-center, retrospective analysis was conducted for patients with PM after gastrectomy from the China National Cancer Center Gastric Cancer Database (NCCGCDB) from 1998 to 2018. Univariate and multivariate Cox regression analyses were performed to identify prognostic factors of overall survival (OS) and recurrence-free survival (RFS). RESULTS: A total of 449 patients were included in the study, including 192 (42.8%) in the proximal PM group (PPM), 205 (45.7%) in the distal PM group (DPM), and 52 (11.6%) in the bilateral PM group (BPM). The 3- and 5-year OS rates for the PM patients investigated were 47.5% and 39.3%, respectively, and the 3- and 5-year RFS rates were 60.0% and 53.6%, respectively. Multivariate Cox regression analysis proved total gastrectomy (hazard ratio (HR): 1.783, 95%CI: 1.133–2.805, p = 0.012), pT4 (HR: 5.264, 95%CI: 1.493–18.565, p = 0.01), pN2 (HR: 2.263, 95%CI: 1.164–4.397, p = 0.016), pN3 (HR: 2.327, 95%CI: 1.233–4.393, p = 0.009), and combined resection (HR: 1.952, 95%CI: 1.256–3.034, p = 0.003) to be independent risk factors of OS, and pT3 (HR: 9.257, 95%CI: 1.152–74.386, p = 0.036) and pT4 (HR: 11.361, 95%CI: 1.469–87.847, p = 0.020) to be independent risk factors for RFS. Adjuvant chemotherapy prolonged OS in the PPM group (p = 0.032) and prolonged RFS in the PPM group (p < 0.001) and the DPM group (p = 0.035) compared with surgery alone. CONCLUSIONS: Advanced pathologic stage was associated with poor prognosis, and postoperative adjuvant chemotherapy might be recommended in PM patients after gastrectomy. Still, further prospective trials are warranted to verify and support our conclusions. Frontiers Media S.A. 2022-02-02 /pmc/articles/PMC8847385/ /pubmed/35186712 http://dx.doi.org/10.3389/fonc.2021.794032 Text en Copyright © 2022 Zhang, Zhao, Niu, Wang, Wang, Sun, Li, Chen and Zhao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Xiaojie
Zhao, Lulu
Niu, Penghui
Wang, Tongbo
Wang, Wanqing
Sun, Chongyuan
Li, Zefeng
Chen, Yingtai
Zhao, Dongbing
Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title_full Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title_fullStr Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title_full_unstemmed Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title_short Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title_sort adjuvant chemotherapy might be recommended to patients with positive margin after gastrectomy: a 20-year retrospective analysis in a single center
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847385/
https://www.ncbi.nlm.nih.gov/pubmed/35186712
http://dx.doi.org/10.3389/fonc.2021.794032
work_keys_str_mv AT zhangxiaojie adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT zhaolulu adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT niupenghui adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT wangtongbo adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT wangwanqing adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT sunchongyuan adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT lizefeng adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT chenyingtai adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT zhaodongbing adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter